View Full Version : wonderful product but society has to be able to afford it

11-30-2005, 09:53 AM
When a treatment for paralysis is available is this what will happen?

Powerful Breast Cancer Drug Carries High Price
var byline = 'By Steven Reinberg
HealthDay Reporter,'; if (byline != null) { document.write(byline.replace(/,[\s]*$/, '')); } By Steven Reinberg
HealthDay Reporter &ltb&gtBy Steven Reinberg&lt/b&gt&ltbr /&gt&lti&gtHealthDay Reporter&lt/i&gt,

TUESDAY, Nov. 29 (HealthDay News) -- The high cost of the potent new breast cancer drug Herceptin could limit its use, a new Belgian study suggests.
Since a year's worth of Herceptin could cost upward of $45,000 in the United States, "there are experts in this country and in insurance agencies and Medicaid that have a lot of decisions to make," said Debbie Saslow, the director of breast and gynecological cancer at the American Cancer Society.
"This is what happens when lifesaving drugs come out that are very expensive," said Saslow, who was not involved in the study.
But even with its high cost, if Herceptin proves to be as effective at fighting early breast cancer as preliminary data suggest, it could still be cost-effective in certain subgroups of women, according to lead researcher Mattias Neyt, a health economist and research fellow at Ghent University.
Currently, Herceptin is licensed for use in advanced breast cancer, where it has been shown to extend survival. Four trials of its use in early breast cancer are under way and preliminary results are promising. There has been pressure from patients and others to make Herceptin available immediately, without waiting for the outcome of these trials.
But Herceptin's expense means that using it as therapy in early breast cancer could be a major financial burden on health-care systems, since large numbers of women might need the drug for long periods of time, the Belgian researchers noted. http://www.forbes.com/lifestyle/health/feeds/hscout/2005/11/29/hscout529378.html